Skip to main content
TipRanks
Go Ultimate75% OFF

Japan Hospice Holdings Inc. (7061) AI Stock Analysis

0 Followers
JP:7061

Japan Hospice Holdings Inc.

(TSE/TYO:7061)

Select Model
Rating:41Neutral
Price Target:JPY 409.00â–²(4.07% Upside)
Action:reiterated
Date:08/18/26

The overall score is heavily pressured by deteriorating financial performance and a persistent technical downtrend. Sharp margin contraction, high debt, and negative free cash flow are the most significant risks. The stock's oversold technical condition and reasonable P/E ratio offer limited offset, as earnings quality remains poor.

Positive Factors
Consistent Revenue GrowthConsistent revenue expansion indicates that the company has continued increasing activity across its hospice and nursing-care operations. Sustained top-line growth provides a foundation for future scale, even though profitability must improve for that growth to translate into stronger shareholder returns.
Negative Factors
High Financial LeverageHigh leverage reduces financial flexibility and leaves the company more exposed to weaker earnings or higher financing costs. Debt has risen substantially while equity remains modest relative to obligations, limiting the capacity to fund expansion, absorb setbacks, or strengthen the balance sheet organically.

Japan Hospice Holdings Inc. (7061) vs. iShares MSCI Japan ETF (EWJ)

-80%-60%-40%-20%0%20%40%JP:7061-69.13%EWJ+16.02%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 3.15B
Dividend Yield
―
Average Volume (3M)
71.46K
Price to Earnings (P/E)
-32.8
Beta (1Y)
0.88
Revenue Growth
6.75%
EPS Growth
-119.69%
Country
Japan
Employees
1,108
Sector
General
Sector Strength
55
Industry
Medical - Care Facilities

Japan Hospice Holdings Inc. Business Overview & Revenue Model

Company Description

Japan Hospice Holdings Inc. operates in Japan, focusing on two primary areas: hospice residential care and a range of home-based support services. Its hospice facilities offer specialized care for patients facing terminal cancer and intractable disea...

Japan Hospice Holdings Inc. Financial Statement Overview

Summary

Revenue growth is positive but overshadowed by severe margin compression, high leverage (3.6x D/E), and deeply negative free cash flow. Net income fell over 50% and ROE dropped to 7.6%, indicating poor financial health.

Income Statement

30Negative

Balance Sheet

25Negative

Cash Flow

25Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue15.08B14.17B12.12B9.87B7.89B6.02B
Gross Profit2.17B1.84B2.11B1.92B1.58B1.12B
EBITDA1.71B1.43B1.82B1.79B1.40B852.01M
Net Income329.39M278.01M639.58M681.88M454.73M240.80M
Balance Sheet
Total Assets18.75B18.92B18.31B15.16B11.45B9.15B
Cash, Cash Equivalents and Short-Term Investments1.93B2.01B1.53B1.88B1.51B1.04B
Total Debt12.00B13.18B13.19B10.89B8.09B6.67B
Total Liabilities15.09B15.25B14.86B12.47B9.41B7.61B
Stockholders Equity3.66B3.68B3.45B2.69B2.01B1.54B
Cash Flow
Free Cash Flow0-1.32B-2.27B-865.26M340.76M-1.45B
Operating Cash Flow01.05B835.74M1.13B873.83M467.10M
Investing Cash Flow0-511.73M-2.79B-1.01B48.27M-1.98B
Financing Cash Flow0-47.03M1.60B256.45M-448.16M1.59B

Japan Hospice Holdings Inc. Technical Analysis

Technical Analysis SentimentNegative
Last Price393.00

Price Trends

50DMA466.66Negative
100DMA505.18Negative
200DMA648.41Negative

Market Momentum

MACD-15.04Positive
RSI30.06Neutral
STOCH24.89Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7061, the sentiment is Negative. The current price of 393.00 is below the 20-day moving average (MA) of 445.50, below the 50-day MA of 466.66, and below the 200-day MA of 648.41, indicating a bearish trend. The MACD of -15.04 indicates Positive momentum. The RSI at 30.06 is Neutral, neither overbought nor oversold. The STOCH value of 24.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7061.

Japan Hospice Holdings Inc. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:7061 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:6062JP:606273OutperformJPY 64.01B14.43―2.19%5.50%45.42%
JP:7071JP:707164NeutralJPY 30.28B9.56―1.30%1.93%-65.20%
JP:2425JP:242556NeutralJPY 2.48B28.24―3.36%-3.64%-66.52%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
JP:2373JP:237352NeutralJPY 5.23B18.30―4.37%4.76%-52.55%
JP:7061JP:706141NeutralJPY 3.33B-32.83――6.75%-119.69%

* General Sector Average

Performance Comparison

-50%0%50%JP:7061JP:2373JP:2425JP:6062JP:7071Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:7061 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:7061Japan Hospice Holdings Inc.393.00-915.32-69.96%
JP:2373Care Twentyone Corporation389.00-50.78-11.55%
JP:2425Care Service Co., Ltd.654.00-106.17-13.97%
JP:6062Charm Care Corporation1963.00765.0663.87%
JP:7071Amvis Holdings.Inc.308.00-142.40-31.62%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 18, 2026